Prescriber Scope of Practice for Depression

If you’re a psychiatrist or PMHNP wondering whether you can legally manage depression patients via telehealth and prescribe their medications remotely, here’s the short answer: Yes — and in most cases, it’s easier than you think in 2026.

But the real question isn’t just ‘can you?’ It’s: What are the actual rules, how do they differ by state and provider type, and what do you need to know to practice compliantly while building a sustainable telehealth practice?

Let’s cut through the regulatory fog. Whether you’re an established psychiatrist looking to expand into telepsychiatry, a PMHNP navigating scope of practice rules, or a provider comparing platforms like Klarity Health to DIY patient acquisition, this guide covers what matters: federal DEA rules, state-specific telehealth laws, scope of practice differences, and the business realities of running a telehealth depression practice in 2026.

The Big Picture: Federal Telehealth Rules Are Provider-Friendly (For Now)

Good news first: The DEA’s COVID-era flexibilities allowing you to prescribe controlled substances via telehealth without an initial in-person exam remain in effect through December 31, 2026. This fourth temporary extension means you can continue initiating treatment for depression — including co-occurring ADHD or anxiety that may require controlled medications — entirely via telemedicine.

For depression-focused providers, this matters because while most first-line antidepressants (SSRIs, SNRIs, bupropion) aren’t controlled substances and face no federal telehealth restrictions, many of your patients have comorbidities. A patient with major depression and severe anxiety might need a short-term benzodiazepine. Someone with treatment-resistant depression might benefit from a stimulant augmentation strategy. Under current rules, you can manage these cases remotely.

The reality check: These are temporary rules. The DEA is working on permanent regulations expected in late 2026, which will likely introduce a new Special Registration for Telemedicine program. The proposed rules (announced January 2025) would allow psychiatrists to obtain an ‘Advanced Telemedicine Prescribing’ registration specifically for Schedule II controlled substances — think Adderall, Ritalin, certain sleep medications. For Schedule III-V drugs (like benzodiazepines), any provider could apply for the standard telemedicine registration.

What this means practically: You can practice telehealth psychiatry now with confidence, but plan for some administrative changes in 2027. You’ll likely need to apply for this special DEA registration, but the system is being designed specifically to accommodate psychiatric practice via telehealth without forcing in-person visits.

For most depression management, this is a non-issue. You’re prescribing non-controlled medications that have never been subject to the Ryan Haight Act’s in-person requirement. But if you’re treating complex cases or managing ADHD alongside depression, understanding these evolving rules protects your practice.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State Laws: Where It Gets Interesting

Federal rules set the floor. State laws can be more restrictive — and they vary wildly, especially around nurse practitioner scope of practice and specific telehealth prescribing requirements.

California: Progressive on Telehealth, Newly Progressive on NP Independence

For Psychiatrists: No special barriers. California doesn’t require an in-person exam before prescribing via telehealth — you just need to meet the standard of care. A thorough video psychiatric evaluation is sufficient to initiate treatment. California has strong telehealth parity laws, meaning private insurers and Medicaid must cover tele-mental health equivalently to in-person.

The catch? California isn’t part of the Interstate Medical Licensure Compact, so out-of-state psychiatrists must obtain a full California medical license to treat California patients via telehealth. No shortcuts.

For PMHNPs: This is where California got interesting. AB 890, signed in 2020 and phased in through 2023-2024, now allows experienced nurse practitioners (including psychiatric NPs) to practice completely independently without physician supervision. If you’ve been practicing for 3+ years with national certification, you can become a ‘103 NP’ (practice in group settings without oversight as of January 2023) or a ‘104 NP’ (fully independent practice statewide as of January 2024).

What this means: A qualified PMHNP in California can run their own telehealth depression practice, diagnose independently, and prescribe all medications (including controlled substances consistent with federal DEA rules) without a supervising psychiatrist. This is a massive shift from California’s historical physician-supervision requirement.

The economic opportunity: California has over 39 million people, significant mental health provider shortages outside major metros, and a patient population that’s comfortable with telehealth. For PMHNPs, the ability to practice independently via platforms like Klarity means you’re not splitting revenue with a supervising physician or navigating collaboration agreements.

Texas: Open for Telehealth, Closed for NP Independence

For Psychiatrists: Texas modernized its telehealth laws in 2017 (SB 1107), removing the old requirement for an in-person visit before telemedicine could establish a patient relationship. You can now see a new patient via live video and prescribe depression medications based on that evaluation.

The exception: Texas explicitly prohibits treating chronic pain with controlled substances via telehealth unless you’ve seen the patient in person within the last 90 days or meet other stringent conditions. This is aimed at opioid prescribing for pain management, not psychiatric care. For depression and anxiety treatment, this doesn’t typically apply — but be aware if you’re managing a patient with depression and chronic pain comorbidity.

Texas also has some of the nation’s worst mental health provider shortages (246 of 254 counties are designated shortage areas), making telepsychiatry both needed and well-reimbursed.

For PMHNPs: Texas requires all APRNs to have a Prescriptive Authority Agreement with a physician. No independent practice, period. Legislation to expand APRN scope has repeatedly failed. The supervising physician doesn’t need to be physically present during telehealth sessions, but you must have regular (monthly) consultation meetings documented, and they’re ultimately responsible for your prescriptive practice.

For Schedule II controlled substances (like stimulants), Texas imposes additional restrictions on NP prescribing — you generally can only prescribe them in hospital-based or hospice settings, not outpatient telehealth.

Business implication: If you’re a PMHNP considering Texas, factor in the cost and complexity of securing a supervising psychiatrist. Some platforms handle this coordination; if you’re going solo, it’s a significant administrative lift. For psychiatrists, Texas is wide open — massive patient demand, clear regulatory framework, and telehealth-friendly reimbursement.

Florida: Surprisingly Friendly for Telepsychiatry (With a Catch)

Florida’s telehealth law is unique: it allows out-of-state providers to register to provide telehealth services without obtaining a full Florida license. This Out-of-State Telehealth Registration (renewed every 2 years) has made Florida accessible to providers nationwide.

The controlled substance exception: Florida law prohibits prescribing Schedule II controlled substances via telehealth except for: psychiatric disorders, inpatient hospital care, hospice, or nursing home residents. For depression providers, this exception is key — you can prescribe Schedule II medications (Adderall, Ritalin, certain sleep aids) via telehealth to Florida patients as long as it’s part of psychiatric treatment.

This makes Florida one of the most telehealth-friendly states for psychiatry. Document clearly that any Schedule II prescription is for a psychiatric indication (ADHD comorbid with depression, treatment-resistant depression augmentation, etc.) and you’re compliant.

For PMHNPs: Here’s the catch — Florida’s 2020 law allowing some NPs to practice autonomously specifically excluded psychiatric mental health NPs. Only primary care NPs (family medicine, internal medicine, pediatrics) can practice independently in Florida. Psychiatric NPs must have a supervising physician and a signed protocol.

If you’re an out-of-state PMHNP, you’ll need not just the telehealth registration but also a Florida-licensed psychiatrist willing to supervise your practice. For some, this is a dealbreaker. For others, partnering with a Florida psychiatrist (who may also benefit from the arrangement) makes it workable.

Market opportunity: Florida has 22 million people, a growing elderly population with high rates of depression, and significant provider shortages. The telehealth registration pathway means a New York or California psychiatrist can access this market without relocating.

New York: Progressive on NP Independence, Standard on Telehealth

For Psychiatrists: New York has no unique telehealth prescribing restrictions. Standard of care applies. The state actively encourages telepsychiatry (especially to serve upstate rural areas), and insurance parity laws ensure good reimbursement.

New York isn’t in the Interstate Medical Licensure Compact, so out-of-state psychiatrists need a full NY license — but New York’s large, underserved patient population makes it worth the investment.

For PMHNPs: New York changed its rules in 2022, making permanent the Nurse Practitioners Modernization Act provisions. Experienced NPs (those with over 3,600 hours of practice) can now practice completely independently — no written collaborative agreement, no physician oversight required.

This means a qualified PMHNP in New York can diagnose depression, prescribe all medications (including controlled substances within their scope), and practice via telehealth without involving a psychiatrist. New NPs still need a collaborative agreement until they hit that experience threshold, but once you’re over it, you have full practice authority.

Regulatory quirk: New York requires electronic prescribing for all medications (with very limited exceptions) and has strict integration with the state’s Prescription Monitoring Program. Ensure your telehealth platform or EHR handles this seamlessly.

Pennsylvania: Friendly in Practice, Unclear in Statute

Pennsylvania doesn’t have a comprehensive telehealth law — various attempts to pass one have failed (often getting caught up in unrelated political disputes). But the Pennsylvania Department of State has made clear that licensed providers can deliver care via telemedicine within their scope of practice as long as it meets standard of care.

For Psychiatrists: You can prescribe via telehealth after a proper evaluation. Pennsylvania defers to federal DEA rules on controlled substances. The state requires electronic prescribing for controlled medications, so ensure compliance with e-prescribing requirements.

Pennsylvania is part of the Interstate Medical Licensure Compact (joined in 2021), making it easier for out-of-state psychiatrists to get licensed.

For PMHNPs: Pennsylvania requires a collaborative agreement with a physician. No full practice authority legislation has passed despite ongoing efforts. The physician doesn’t need to co-sign each prescription or attend telehealth sessions, but the agreement must outline scope and oversight, and they’re ultimately responsible.

Market context: Pennsylvania has significant rural mental health shortages (the ‘Pennsyltucky’ region), and state agencies actively promote telepsychiatry. Medicaid and most private insurers reimburse telehealth equivalently to in-person.

Illinois: Gold Standard for Telehealth and NP Practice

Illinois has one of the most provider-friendly regulatory environments for telepsychiatry.

For Psychiatrists: The state’s 2021 Telehealth Expansion Act mandated insurance parity, prohibited geographic restrictions (you can treat patients anywhere in Illinois from anywhere in Illinois), and explicitly allowed telehealth from patients’ homes. No in-person exam requirement — standard of care is the guide.

Illinois is in the Interstate Medical Licensure Compact, streamlining out-of-state licensing.

For PMHNPs: Illinois offers Full Practice Authority for experienced APRNs. After completing 4,000 hours of clinical practice under collaboration plus 250 hours of additional education, a PMHNP can apply for APRN-FPA status. With FPA, you practice and prescribe completely independently — including controlled substances.

Illinois does require FPA APRNs to have a consultation relationship with a physician for extended Schedule II opioid prescriptions (a safeguard against pain management abuse), but this rarely affects psychiatric practice for depression.

Why this matters: An experienced PMHNP with FPA in Illinois can join a platform like Klarity and see patients independently, without splitting revenue or coordinating with a supervising physician. For depression treatment specifically — largely non-controlled medications with occasional benzodiazepines or sleep aids — you have full autonomy.

Illinois also allows audio-only telehealth for behavioral health when appropriate, though video is preferred for new patient evaluations.

Psychiatrists vs PMHNPs: Understanding Scope Differences

Both psychiatrists and PMHNPs can effectively manage depression via telehealth, but there are important differences in scope and autonomy that affect your practice structure and earning potential.

Psychiatrists (MD/DO)

Scope: Unrestricted. You can diagnose any psychiatric condition, prescribe any medication (controlled or non-controlled), provide psychotherapy, and manage complex cases independently. Every state recognizes your full authority — the only variable is licensing (you need a license in each state where patients are located).

Controlled substance authority: You have your own DEA registration and can prescribe Schedule II-V medications nationwide (subject to federal DEA rules and any state-specific limits like Texas’s chronic pain restrictions). When the DEA’s permanent telemedicine registration system launches, psychiatrists are explicitly included in the ‘Advanced Telemedicine Prescribing’ category for Schedule II drugs.

Business model: Maximum flexibility. You can practice solo via telehealth, join a group, or work through a platform. No supervision requirements mean you keep 100% of revenue (minus platform fees if applicable) and control your schedule completely.

The trade-off: Medical school debt, longer training pathway, and potentially higher malpractice insurance costs. But for complex cases, treatment-resistant depression, or patients requiring medication management plus therapy, psychiatrists command premium rates.

Psychiatric Mental Health Nurse Practitioners (PMHNPs)

Scope: Comprehensive mental health assessment, diagnosis of psychiatric disorders, prescribing of psychiatric medications, and provision of therapy/counseling. Your scope is determined by state law — and this is where it gets complicated.

Full Practice Authority States (California, New York, Illinois for experienced NPs):

• Diagnose and treat depression independently
• Prescribe all medications including controlled substances (within your specialty scope)
• No physician supervision or collaboration required
• Own DEA registration for controlled substances
• Can open your own practice or join platforms without needing an MD partner

Restricted Practice States (Texas, Florida, Pennsylvania):

• Must have a written collaborative agreement or supervisory relationship with a physician
• Prescribing authority delegated by the physician (though you’re doing the actual prescribing)
• Some states limit Schedule II prescribing by NPs or require physician involvement
• Cannot practice independently via telehealth — need an MD relationship

Controlled substance nuances: Even in full-practice states, NPs sometimes face additional requirements. For example, Illinois FPA-NPs must complete 45 hours of pharmacology continuing education to prescribe controlled substances. Texas limits NP Schedule II prescribing to very specific settings (hospital, hospice), making outpatient telepsychiatry for ADHD comorbid with depression challenging for NPs.

Business implication: In full-practice states, PMHNPs have nearly the same business model flexibility as psychiatrists — you can practice solo, keep full revenue, and manage patients autonomously. In restricted states, you need to factor in collaboration costs (some supervising psychiatrists charge a monthly fee, others want a revenue split) and administrative complexity.

The upside: Shorter, less expensive training pathway than medical school. Strong demand for PMHNPs nationwide. In full-practice states, earning potential approaches psychiatrist levels for medication management work, especially via high-volume telehealth.

The Economics of Telehealth Depression Practice: Platform vs DIY

Here’s where we get real about money and patient acquisition.

You can build a telehealth depression practice two ways:

1. DIY marketing — build your own website, run Google Ads, optimize for SEO, list on directories
2. Join a platform like Klarity Health that handles patient acquisition and infrastructure

Let’s talk economics honestly.

DIY Marketing: The Hidden Costs

The typical narrative: ‘Acquire patients for cheap via SEO and Google Ads, keep 100% of revenue.’

The reality: Acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ all-in when you factor in:

• Google Ads: Mental health keywords like ‘depression treatment near me’ or ‘ADHD psychiatrist’ cost $15-40+ per click. Most clicks don’t book appointments. A realistic cost per booked patient is $200-400+ after accounting for click-through rates, no-shows from cold leads, and campaign optimization costs.

• SEO: Takes 6-12 months of consistent investment (content creation, technical optimization, local citations, backlinks) before generating meaningful patient flow. Unless you’re doing it yourself (which means hours away from seeing patients), you’re paying an agency $2,000-5,000/month with no guaranteed results for months.

• Directory listings: Psychology Today, Zocdoc, Headway, etc. charge monthly subscription fees ($50-300/month) and often take a per-booking fee ($35-100+). You’re competing with hundreds of other providers on the same platform. Conversion rates vary wildly.

• Staff time: Someone has to answer calls, qualify leads, handle scheduling, follow up on no-shows. If you’re doing it yourself, that’s billable hours lost. If you’re hiring, factor in $15-25/hour for admin support.

• Failed campaigns: Most solo providers waste $3,000-10,000 testing channels that don’t work before finding what does.

When DIY makes sense: If you have $10,000-20,000 to invest upfront, 6-12 months to wait for ROI, and either expertise in healthcare marketing or budget to hire an agency. Once it’s working, your marginal cost per patient can eventually drop below $100 — but you’re gambling significant capital to get there.

For most providers starting out or scaling quickly, DIY marketing is a high-risk, high-effort path.

Platform Model: Pay-Per-Patient vs Monthly Marketing Spend

Platforms like Klarity Health use a pay-per-appointment model — you pay a listing fee when a qualified patient books with you.

How to think about this economically:

Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay only when you see patients. The platform handles:

• Patient acquisition (they’re already spending on ads, SEO, and brand)
• Pre-qualification (patients matched to your specialty and availability)
• Telehealth infrastructure (no separate platform subscription)
• Scheduling and admin (automated systems reduce no-shows)
• Insurance credentialing support (for insurance-based patients) or cash-pay processing

The trade-off: You pay a per-appointment fee (similar to Zocdoc’s model). For some platforms, this might be $35-100+ per new patient encounter. The key question: What’s your guaranteed ROI?

If the platform delivers a patient who shows up, has insurance (or pays cash), and becomes an ongoing medication management patient, that initial listing fee is offset by lifetime value. A depression patient on medication management might see you monthly for years — 12-24 appointments annually. If you charge $150-250 per follow-up and the platform fee is only on the first visit (or a lower percentage on follow-ups), the economics work strongly in your favor.

Real numbers example:

• DIY route: Spend $4,000/month on marketing → maybe get 8-15 new patients/month after 6 months of optimization → all-in cost $250-500/patient acquisition before factoring in your time
• Platform route: Zero upfront spend → get 8-15 new patients/month immediately → pay listing fee per patient → guaranteed ROI because you only pay when you actually see someone

When platforms make sense:

• You’re starting out and don’t have marketing budget or expertise
• You want to scale quickly without gambling on ad spend
• You value time (seeing patients) over building marketing infrastructure
• You want predictable economics (know exactly what each patient costs)

For established providers with successful DIY marketing, platforms can be additive — a way to fill schedule gaps without increasing ad spend. For newer providers or those expanding to new states, platforms remove the patient acquisition risk entirely.

What About Non-Controlled Depression Medications?

Here’s the simplest part of this entire regulatory landscape: If you’re only prescribing non-controlled antidepressants, federal telehealth restrictions don’t apply at all.

SSRIs (Prozac, Zoloft, Lexapro), SNRIs (Effexor, Cymbalta), bupropion (Wellbutrin), mirtazapine, trazodone — these are legend drugs but not controlled substances. The DEA doesn’t regulate them under the Ryan Haight Act.

State laws still apply (you need a valid patient relationship via telehealth encounter, you must meet standard of care, you need to be licensed in the patient’s state), but there’s no in-person exam requirement anywhere for prescribing an SSRI after a proper video evaluation.

This means the vast majority of depression treatment via telehealth is completely straightforward from a regulatory standpoint. The complexity only arises when managing comorbid conditions requiring controlled substances.

Practical Compliance Checklist for Telehealth Depression Prescribing

Federal Requirements (All Providers):

• ✅ Valid DEA registration in each state you practice (if prescribing controlled substances)
• ✅ Compliance with current DEA telehealth rules (temporary extension through 12/31/2026)
• ✅ Plan for upcoming DEA Special Registration for Telemedicine (expected late 2026)
• ✅ HIPAA-compliant telehealth platform (encrypted video, secure messaging)

State-Specific Requirements:

• ✅ Medical license or APRN license in each state where patients are located
• Consider Interstate Medical Licensure Compact (IMLC) for physicians
• Check if state offers out-of-state telehealth registration (Florida model)
• ✅ Collaborative agreement if required for NPs (Texas, Florida, Pennsylvania)
• ✅ Check state’s Prescription Drug Monitoring Program (PDMP) when prescribing controlled substances
• ✅ Use electronic prescribing (mandatory in many states, especially for controlled substances)
• ✅ Document patient consent for telehealth services
• ✅ Maintain documentation meeting state standard-of-care requirements

For PMHNPs Specifically:

• ✅ Verify your state’s scope of practice laws (full practice authority vs collaboration required)
• ✅ Ensure supervising physician is licensed in same state if required
• ✅ Complete any state-mandated continuing education (e.g., Illinois’s 45 hours pharmacology for controlled substances)
• ✅ Understand limitations on Schedule II prescribing in your state

For Controlled Substance Prescribing:

• ✅ Conduct thorough initial evaluation (video strongly preferred over audio-only)
• ✅ Screen for substance use history and contraindications
• ✅ Check state PDMP before prescribing
• ✅ Document medical necessity clearly (especially for Schedule IIs)
• ✅ Follow up appropriately (monthly for ongoing controlled medications)
• ✅ Be aware of state-specific exceptions (e.g., Florida’s psychiatric disorder exception, Texas’s chronic pain prohibition)

Emergency Planning:

• ✅ Have protocol for psychiatric emergencies during telehealth sessions
• ✅ Know how to activate local emergency services in patient’s location
• ✅ Document emergency contact information for all patients
• ✅ Consider scope limitations (when to refer to ER vs crisis line vs urgent in-person evaluation)

State Comparison: Quick Reference for Depression Providers

What This Means for Your Practice

If you’re a psychiatrist, telehealth depression practice in 2026 is wide open. Choose your states based on market demand and licensing convenience (IMLC states make multi-state practice easier). Focus your time on patient care, not regulatory hurdles.

If you’re a PMHNP, your path depends on where you practice:

• In full-practice states (CA, NY, IL with appropriate experience), you have nearly identical business opportunities to psychiatrists
• In restricted states (TX, FL, PA), factor in collaboration requirements when evaluating platforms or solo practice economics

For both provider types, the choice between DIY marketing and joining a platform like Klarity comes down to risk tolerance and time horizon:

• Platform: Lower risk, faster patient flow, predictable costs, less time building infrastructure
• DIY: Higher upfront investment, longer timeline to ROI, eventual lower cost per patient if successful, full control

The regulatory environment is moving in a favorable direction — expanding telehealth access while introducing reasonable safeguards. For depression providers specifically, most of what you do (prescribing non-controlled antidepressants) faces minimal barriers. The complexity is at the edges (controlled medications for comorbidities, state NP scope variations), but it’s navigable with the right information.

Next Steps: Getting Started with Telehealth Depression Practice

If you’re ready to expand into telehealth or scale your existing practice:

1. Verify your licenses in target states and understand scope limitations (especially if you’re a PMHNP)
2. Choose your patient acquisition strategy — evaluate whether a platform model or DIY marketing fits your timeline and budget
3. Ensure compliance infrastructure — HIPAA-compliant video, electronic prescribing, PDMP access
4. Stay updated on DEA rules — the Special Registration for Telemedicine will require action in late 2026
5. Document everything — telehealth malpractice risk is mostly about documentation, not clinical care

Interested in joining Klarity Health’s provider network?

Klarity handles the patient acquisition headache (no upfront marketing spend, no gambling on Google Ads that might not convert) and provides the telehealth infrastructure. You focus on what you do best: evaluating patients, managing medications, and delivering quality psychiatric care.

We work with both psychiatrists and PMHNPs (in states where NP scope allows independent practice or where we can facilitate collaboration). Our model is simple: pay-per-appointment listing fees, pre-qualified patients matched to your availability and specialty, both insurance and cash-pay patient flow.

No monthly subscriptions. No wasted ad spend. No patient acquisition risk. Just qualified patients ready to see you.

Explore Klarity’s provider platform and see how telehealth depression practice can fit into your career — whether you’re starting out, scaling up, or just want to fill schedule gaps without the marketing hassle.

FAQ: Telehealth Depression Prescribing

Can I prescribe antidepressants via telehealth without ever seeing a patient in person?

Yes. For non-controlled antidepressants (SSRIs, SNRIs, bupropion, etc.), there’s no federal or state requirement for an initial in-person visit. You just need to establish a valid patient relationship via a proper telehealth evaluation (typically video) that meets the standard of care.

What about controlled substances like benzodiazepines or stimulants for patients with depression and comorbid anxiety or ADHD?

Under current federal rules (through December 31, 2026), you can prescribe controlled substances via telehealth without an in-person exam thanks to DEA’s temporary extension of COVID-era flexibilities. Always check your state’s specific rules — some states have additional restrictions (like Texas’s chronic pain prohibition or Florida’s requirement that Schedule IIs be for psychiatric disorders).

Do I need a separate DEA registration for telehealth?

Not yet. Currently, you practice under your existing DEA registration. The DEA has proposed a Special Registration for Telemedicine program expected to launch in late 2026, which will require an additional registration to continue prescribing certain controlled substances via telehealth long-term.

Can I treat patients in multiple states via telehealth?

Yes, but you need a license (or valid telehealth registration) in each state where patients are located. The Interstate Medical Licensure Compact (IMLC) for physicians or Florida’s out-of-state telehealth registration can simplify multi-state practice. Check each state’s licensing requirements.

As a PMHNP, can I practice independently via telehealth?

It depends on the state. In full-practice states like California (experienced NPs via AB 890), New York (>3,600 hours), and Illinois (FPA-approved NPs), yes. In states requiring collaboration (Texas, Florida, Pennsylvania), you need a supervising physician relationship even for telehealth practice.

What if my patient is in crisis during a telehealth session?

Have a documented emergency protocol. Know how to contact emergency services in the patient’s location. Obtain emergency contact information for all patients at intake. If a patient is acutely suicidal or psychotic, telehealth has limitations — you may need to direct them to an emergency room or activate 911 in their location.

Are insurance reimbursement rates different for telehealth vs in-person?

Most states now have telehealth parity laws requiring equivalent reimbursement. Check your specific payer contracts and state Medicaid rules. Generally, psychiatric telehealth is well-reimbursed — insurers recognize it as cost-effective and increases access.

How do I handle prescriptions across state lines?

You must be licensed in the state where the patient is located. You’ll need a DEA registration in that state if prescribing controlled substances. Use electronic prescribing, and the prescription will go to a pharmacy in the patient’s state. Check that state’s PDMP before prescribing controlled medications.

What’s the difference between joining a platform like Klarity vs building my own telehealth practice?

Platforms handle patient acquisition, infrastructure, and often credentialing. You pay per patient (or a platform fee) but avoid upfront marketing costs and get immediate patient flow. Building your own practice gives you full control and potentially lower long-term costs per patient, but requires significant upfront investment ($10,000-20,000+) and 6-12 months before meaningful ROI.

Will the DEA rules change in 2027 affect my ability to manage depression patients via telehealth?

Unlikely to significantly impact routine depression care. Most depression medications aren’t controlled substances. For controlled medications (benzodiazepines, stimulants), the proposed Special Registration system is designed specifically to accommodate psychiatric practice. Psychiatrists will likely qualify for the Advanced Telemedicine Prescribing registration for Schedule IIs. The changes are more about formalizing what’s currently allowed temporarily rather than restricting access.

References and Sources

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026’ (January 2, 2026) – Official announcement of DEA rule extension. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. DEA Press Release – ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Vital Medications’ (January 16, 2025) – Details on proposed Special Registration for Telemedicine and permanent rulemaking. https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access

3. California Board of Registered Nursing – AB 890 Implementation guidance on independent nurse practitioner practice (Updated January 2023) – Official state information on NP scope expansion in California. https://www.rn.ca.gov/practice/ab890.shtml

4. Florida Statutes §456.47 – Use of Telehealth to Provide Services – Florida’s telehealth law including out-of-state registration and controlled substance exceptions. https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html

5. Texas Administrative Code Title 22, Part 9 §174.5 – Telemedicine Medical Services, Telemedicine Medical Service Issuance of Prescriptions (Last updated January 15, 2025) – Texas Medical Board rules on telehealth prescribing including chronic pain restrictions. https://txrules.elaws.us/rule/title22chapter174sec.174.5

6. New York NP Independence Analysis – ‘New Law Allows Experienced NPs to Practice Independently in NY’ by RivkinRounds (April 13, 2022) – Legal analysis of New York’s permanent NP independence law. https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/

7. Pennsylvania Department of State – Telemedicine FAQs for Licensed Professionals – Official state guidance on telehealth practice

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,disruptions%20in%20care%20while%20permanent
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=These%20rules%20are%20a%20result,temporary%20rule%20until%20December%202025
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=is%20accessible%20for%20medical%20care,is%20being%20prescribed%20controlled%20medication
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%20law%20previously%20allowed,based%20on%20only
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,person%20setting
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,be
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,through%20a%20telemedicine%20medical%20service